Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Greiner

Showing results (391-400 of 479) with videos related to

Pageof 48
Sort By:
Journal of Cellular Biochemistry|January 14, 2010
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populationsXiao-Ming Wang, Timothy C Greiner, Marina Bibikova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantationThomas G Gross, John C Bucuvalas, Julie R Park, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphomaKai Fu, Dennis D Weisenburger, William W L Choi, et al.
Blood|March 16, 2002
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profileJames Z Huang, Warren G Sanger, Timothy C Greiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximabPaul N Meyer, Kai Fu, Timothy C Greiner, et al.
British Journal of Haematology|April 23, 2013
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 casesAnamarija M Perry, David Crockett, Bhavana J Dave, et al.
Transplantation Proceedings|September 25, 2002
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppressionT Jungraithmayr, A Staskewitz, G Kirste, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
Pageof 48

Showing results (391-400 of 479) with videos related to

Sort By:
Pageof 48
Journal of Cellular Biochemistry|January 14, 2010
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populationsXiao-Ming Wang, Timothy C Greiner, Marina Bibikova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantationThomas G Gross, John C Bucuvalas, Julie R Park, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphomaKai Fu, Dennis D Weisenburger, William W L Choi, et al.
Blood|March 16, 2002
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profileJames Z Huang, Warren G Sanger, Timothy C Greiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximabPaul N Meyer, Kai Fu, Timothy C Greiner, et al.
British Journal of Haematology|April 23, 2013
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 casesAnamarija M Perry, David Crockett, Bhavana J Dave, et al.
Transplantation Proceedings|September 25, 2002
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppressionT Jungraithmayr, A Staskewitz, G Kirste, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
Pageof 48